Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Rick

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Die Rehabilitation|January 21, 2021
[Role of Clinical, Sociomedical and Psychological Factors on Return to Work of Patients with Breast Cancer 6 Months after Rehabilitation]Oliver Rick, Monika Reuß-Borst, Timm Dauelsberg, et al.
Psycho-Oncology|May 18, 2018
NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancerOliver Rick, Monika Reuß-Borst, Timm Dauelsberg, et al.
Urologie (Heidelberg, Germany)|March 25, 2026
[Perioperative therapy for muscle-invasive bladder cancer-current treatment concepts]Günter Niegisch, Georgios Gakis, Carsten H Ohlmann, et al.
Haematologica|March 1, 2002
Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host diseaseJohannes Schetelig, Nicolaus Kröger, Thomas K Held, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study GroupJörg T Hartmann, Thomas Gauler, Bernd Metzner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2026
Social inequalities in return-to-work among colorectal cancer survivors in GermanyJohannes Soff, Ibrahim Demirer, Nora Tabea Sibert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study GroupAnja Lorch, Christian Kollmannsberger, Joerg Thomas Hartmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 23, 2025
Longitudinal development and clinical predictors of financial toxicity among radiation oncology patients: final results of the SOCOFIN studyAnna Luisa Kreuser, Sonia Ziegler, Stephanie Bendrich, et al.
Urologia Internationalis|January 7, 2021
Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized StagesSabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
Urologia Internationalis|January 24, 2021
Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II - Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive TherapySabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Die Rehabilitation|January 21, 2021
[Role of Clinical, Sociomedical and Psychological Factors on Return to Work of Patients with Breast Cancer 6 Months after Rehabilitation]Oliver Rick, Monika Reuß-Borst, Timm Dauelsberg, et al.
Psycho-Oncology|May 18, 2018
NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancerOliver Rick, Monika Reuß-Borst, Timm Dauelsberg, et al.
Urologie (Heidelberg, Germany)|March 25, 2026
[Perioperative therapy for muscle-invasive bladder cancer-current treatment concepts]Günter Niegisch, Georgios Gakis, Carsten H Ohlmann, et al.
Haematologica|March 1, 2002
Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host diseaseJohannes Schetelig, Nicolaus Kröger, Thomas K Held, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study GroupJörg T Hartmann, Thomas Gauler, Bernd Metzner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2026
Social inequalities in return-to-work among colorectal cancer survivors in GermanyJohannes Soff, Ibrahim Demirer, Nora Tabea Sibert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study GroupAnja Lorch, Christian Kollmannsberger, Joerg Thomas Hartmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 23, 2025
Longitudinal development and clinical predictors of financial toxicity among radiation oncology patients: final results of the SOCOFIN studyAnna Luisa Kreuser, Sonia Ziegler, Stephanie Bendrich, et al.
Urologia Internationalis|January 7, 2021
Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized StagesSabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
Urologia Internationalis|January 24, 2021
Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II - Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive TherapySabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
Pageof 4